These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34556087)

  • 1. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study.
    Tanjak P; Suktitipat B; Vorasan N; Juengwiwattanakitti P; Thiengtrong B; Songjang C; Therasakvichya S; Laiteerapong S; Chinswangwatanakul V
    BMC Cancer; 2021 Sep; 21(1):1045. PubMed ID: 34556087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.
    Guzzinati S; Buja A; Grotto G; Zorzi M; Manfredi M; Bovo E; Del Fiore P; Tropea S; Dall'Olmo L; Rossi CR; Mocellin S; Rugge M
    Front Public Health; 2023; 11():1195458. PubMed ID: 37397750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence combination of multiple primary malignant tumors of the digestive system.
    Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
    World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.
    Aydiner A; Karadeniz A; Uygun K; Tas S; Tas F; Disci R; Topuz E
    Am J Clin Oncol; 2000 Aug; 23(4):364-70. PubMed ID: 10955865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
    Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
    J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of modern surgical therapy for multiple primary lung cancers.
    Adebonojo SA; Moritz DM; Danby CA
    Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous and metachronous cancers in patients with gastric cancer.
    Eom BW; Lee HJ; Yoo MW; Cho JJ; Kim WH; Yang HK; Lee KU
    J Surg Oncol; 2008 Aug; 98(2):106-10. PubMed ID: 18452218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients.
    Jiao F; Yao LJ; Zhou J; Hu H; Wang LW
    Asian Pac J Cancer Prev; 2014; 15(1):331-4. PubMed ID: 24528052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis.
    Nemes A; Todor N; Nagy V
    J BUON; 2018; 23(6):1846-1854. PubMed ID: 30610812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.
    Panosetti E; Luboinski B; Mamelle G; Richard JM
    Laryngoscope; 1989 Dec; 99(12):1267-73. PubMed ID: 2601541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
    Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
    Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.
    Verrico M; Rossi L; Tomao S; Colonna M; Vici P; Tomao F
    Oncology; 2020; 98(1):10-15. PubMed ID: 31505502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
    Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
    Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Synchronous and Metachronous Colorectal Cancer: Population-Based Estimates in Denmark with Focus on Non-Hereditary Cases Diagnosed After Age 50.
    Lindberg LJ; Ladelund S; Bernstein I; Therkildsen C; Nilbert M
    Scand J Surg; 2019 Jun; 108(2):152-158. PubMed ID: 30196753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.
    Ławniczak M; Gawin A; Jaroszewicz-Heigelmann H; Rogoza-Mateja W; Raszeja-Wyszomirska J; Białek A; Karpińska-Kaczmarczyk K; Starzyńska T
    World J Gastroenterol; 2014 Jun; 20(23):7480-7. PubMed ID: 24966619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.